GSK plc (LON:GSK)
1,825.82
+1.32 (0.07%)
Dec 15, 2025, 12:09 PM BST
GSK plc Employees
GSK plc had 68,629 employees as of December 31, 2024. The number of employees decreased by 1,583 or -2.25% compared to the previous year.
Employees
68,629
Change (1Y)
-1,583
Growth (1Y)
-2.25%
Revenue / Employee
468.69K GBP
Profits / Employee
80.05K GBP
Market Cap
73.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68,629 | -1,583 | -2.25% |
| Dec 31, 2023 | 70,212 | 812 | 1.17% |
| Dec 31, 2022 | 69,400 | -20,696 | -22.97% |
| Dec 31, 2021 | 90,096 | -3,970 | -4.22% |
| Dec 31, 2020 | 94,066 | -5,371 | -5.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Spire Healthcare Group | 15,703 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
GSK plc News
- 2 days ago - GSK: Depemokimab And Jemperli Lead Next Wave (Rating Upgrade) - Seeking Alpha
- 2 days ago - GSK's $4 Billion Asthma Drug Gets First-Ever Green Light in Europe - GuruFocus
- 2 days ago - GSK Gets FDA Nod for Blujepa in Uncomplicated Urogenital Gonorrhea - Nasdaq
- 2 days ago - GSK Gains CHMP Recommendation for Nucala in COPD Treatment - GuruFocus
- 2 days ago - GSK's Depemokimab Receives CHMP Approval Recommendation for Asthma and CRSwNP - GuruFocus
- 2 days ago - GSK gets EU regulator backing for expanded use of RSV vaccine - Reuters
- 2 days ago - European health regulator recommends approval for GSK's twice yearly asthma drug - Reuters
- 2 days ago - GSK (GSK) Receives EMA Panel Endorsement for Expanded Arexvy Vaccine Use - GuruFocus